Latest Breaking News On - Shigero saito - Page 1 : comparemela.com

A new device called bioadaptable, as opposed to bioabsorbable, was noninferior to a widely used drug eluting stent, and associated with several vessel functional improvements, in the BIOADAPTER trial.

New zealandUnited statesRon waksmanShigero saitoEuropean association of percutaneous cardiovascular interventionsMedstar hospital centerShonan kamakuraEuropean associationPercutaneous cardiovascular interventionsElixir medicalMyocardial infarctionDrug eluting stentCoronary stentHealthcare and medical technologyEalth and medical techEalth and med tech